Module 4: Disorders of Hemostasis (from review- Coagulation disorders) Flashcards

1
Q

coagulation disorders are due to (4)

A

Failure of synthesis
Production of abnormal molecules
Excessive destruction or consumption of factors
Inactivation of factor by circulating anticoagulants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Screening tests

A

PT

PTT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PT test is for which factors

A

Extrinsic
Factors II, V, VII, X, I

Silly
Sluts
Love
Pillow
Fights
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

PTT test is for which factors

A

Intrinsic
All factors except III, VII, XIII

Horney
Prostitutes
Have
Coitus
And
Spread
Legs
For
Precious
Pennies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Inherited disorders

A

all factors can be deficient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

3 common inherited disorders

A
Hemophilia A (factor VIIIc)
Hemophilia B (factor IX), christmas disease
Von Willebrands Disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Severity of bleeds %

A

For factors IX, VIII, X, V, II, I

Severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What factors cause a marked prolonged PTT but no clinical bleeding (3)

A

XII, HMWK, PK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What factors cause a disproportionate mild bleed (2)

A

XI, VII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What factors cause a disproportionate severe bleed (1)

A

XIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Normal male and normal female

A

children all normal unless there is a mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Normal male and carrier female (undiagnosed)

A

most common combination which perpetuates the disease

produces XhX, XX, XhY, XY

50% normal (male and female)
25% carriers (female)
25% hemophiliacs (male)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the most common bleeding disorder

A

von willebrands disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the most common hemophilia

A

Hemophilia A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hemophilia A

A

Factor deficient: VIIIc
Gene affected: Xq28
Therapy: factor VIII infusion
Complication: development of immune VIII antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hemophilia B

A

Factor deficient: IX
Gene affected:Xq27
Therapy: Prothrombin group concentrate or IX concentrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which hemophilia therapy lasts longer and why

A

IX because of its longer half-life

Therapy is given less often which reduced the chance of developing antibodies against the therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What type of disorder is Von Willebrands disease

A

platelet adhesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

von Willebrands Disease

A

What chromosome is affected: 12
Treatment: VIII concentrate
Tests for workup: Plt agglutination with ristocetin, plt aggregation with ristocetin (reduced)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

3 types of von Willebrands Disease

A

Type 1 (most common)
Type 2
Type 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Lab findings for Hemophilia A

A

Plt count: normal
Bleeding time: normal
PT: normal
PTT: prolonged

22
Q

Lab findings for Hemophilia B

A

Plt count: normal
Bleeding time: normal
PT: normal
PTT: prolonged

23
Q

Lab findings for von Willebrands Disease, Type 1

A

Plt count: normal
Bleeding time: usually prolonged
PT: normal
PTT: usually normal but may be prolonged

24
Q

Acquired coagulation deficiencies (5 types)

A
Much more common than inherited
Circulating abnormal anticoagulants and antifactors
Vitamin K deficiency
Liver Disease
DIC
Disorders of Fibrinolysis
25
Circulating abnormal anticoagulants and antifactors
A) specific factor antibodies B) non-specific inhibitors "antiphospholipid antibody" -Lupus anticoagulant -Anticardiolipin antibody Test used to differentiate deficiency from circulating anticoagulants or antifactors: mixing study
26
Vitamin K deficiency
factors are not caboxylated and cannot bind calcium Factors involved: Prothrombin group (II, VII, IX, X) and Protein C and S PIVKA stands for: Proteins induced by vitamin K absence = non carboxylated, inactive abnormal prothrombin factor molecules Oral anticoagulant: Warfarin (Coumadin)
27
Liver Disease
reduced production in diseased hepatic cells Factors involved: II, VII, IX, X, V, I
28
2 liver disorders that affect coagulation
Obstructive jaundice :cannot absorb Vitamin K Severe hepatitis: Damaged cells produce less factor
29
3 things destruction of liver cells may result in
DIC: coagulation factors are not removed Released increased amounts of tPA from hepatic cell triggering fibrinolysis Spenomegaly, increasing splenic sequestering of platelets
30
DIC results in
widespread intravascular coagulation and secondary fibrinolysis Results in: consumption and destruction of coag factors until they are deficient; thrombocytopenia; abnormal bleeding
31
causes of DIC
any situation which causes exposure of a lot of foreign surfaces to the blood, or the widespread release of coagulation activators (FIII) or activators of fibrinolysis
32
DIC laboratory findings should confirm (4)
activation of coagulation activation of fibrinolysis inhibitor consumption end organ damage or failure
33
Main lab results for DIC
``` Factor deficiencies (cause prolonged PT/PTT) Thrombocytopenia Increased fdp, FDP Increased D-dimer Schistocytes (broken up RBC) ```
34
Disorders of fibrinolysis
Primary: activation of fibrinolysis in the absence of coagulation Secondary: whenever fibrin is deposited as normal (but if abnormal DIC) Therapeutic: injection of direct plasminogen activators Impaired Fibrinolysis: due to decreased production, increased destruction or increased inhibition of plasminogen, plasminogen activators or plasmin
35
Differentiate primary from secondary fibrinolysis
Fibrinogen degradation product test: Primary = pos Secondary = pos D dimer test: Fibrin degradation products: Primary = NEG secondary = pos
36
Thrombosis is
abnormal formation in circulation of solid, localized masses of fibrin and/or platelets that cause partial or complete blockage of vessels
37
Thromboembolism
thrombi break away and block smaller vessels
38
pulmonary embolism is
obstruction of pulmonary artery or branch of | Usually from DVT (deep vein thrombosis)
39
3 factors involved in forming a thrombus are
slowed blood flow hypercoagulability vessel wall damage
40
thrombi
multiple blood clots
41
thrombus
single blood clot
42
Inherited disorders
``` Factor V leiden gene mutation (protein C resistance) Antithrombin III Protein C or S deficiency Homocysteinuria Dysfibrinogenemia Abnormal plasminogen Prothrombin G20210A Variant ```
43
What immune condition is an acquired coagulation deficiency and also an acquired disorder that promotes thrombosis
lupus anticoagulant
44
Factor V Leiden gene mutation (protein C resistance)
most common cause of increased risk of venous thrombosis Produce an abnormal factor V molecule that resists the action of activated protein C, thus the factor is inappropriately maintained in an active form and therefore continues to promote coagulation
45
Antithrombin III
normally works with heparin to inhibit factors Inadequate inhibition of thrombin, Xa and IXa
46
Protein C or S deficiency
inadequate inhibition of V and VIII | impaired activation of fibrinolysis because activated protein C inhibits antiplasmin
47
Homocysteinuria
damaged endothelium by deposits of amino acid causes activation of coagulation and atherosclerosis
48
Dysfibrinogenemia
abnormal fibrinogen makes abnormal fibrin that will not neutralize thrombin
49
Abnormal plasminogen
impaired formation of plasmin
50
Prothrombin G20210A variant
abnormal allele of II = increased II levels = increased thrombosis